IMARC Group’s latest research report, titled “Smart Inhalers Market Share: Global Industry Trends, Size, Growth, Opportunity, and Forecast 2022-2027,” The global smart inhalers market reached a value of US$ 162.75 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 630.25 Million by 2027, exhibiting a CAGR of 27.30% during 2022-2027. Smart inhalers refer to sensor-enabled digital devices that are widely used to deliver a variety of drugs by inhalation. They use insulin, beta-agonists, anti-cholinergic, and glucocorticoids to treat and prevent respiratory diseases, such as chronic obstructive pulmonary disease (COPD), chronic bronchitis, and asthma. They are equipped with sensors as clip-on to inhalers to monitor the correct dose per intake.
Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/smart-inhalers-market/requestsample
Important Attribute and highlights of the Report:
- Detailed analysis of the global market share
- Market Segmentation by product, indication and distribution channel.
- Historical, current, and projected size of the market in terms of volume and value
- Latest industry trends and developments
- Competitive Landscape for Smart Inhalers Market
- Strategies of major players and product offerings
The global market is majorly driven by the rising prevalence of chronic obstructive pulmonary disease (COPD) and asthma among the masses. This can be attributed to the growing air pollution through natural phenomena and anthropogenic sources. Apart from this, continuous technological advancements across the globe have led to the rising demand for new-age digital technology, which is creating a positive market outlook. Other factors, including extensive research and development (R&D) activities conducted by key players, the increasing awareness regarding preventive care among individuals, and considerable improvements in the healthcare infrastructure, are also positively influencing the market.
Key Players Included in Global Smart Inhalers Market Research Report:
- 3M Company
- Adherium Limited
- AptarGroup Inc.
- AstraZeneca plc
- Boehringer Ingelheim
- Cognita Labs
- GlaxoSmithKline plc
- Novartis AG
- OPKO Health Inc.
- Propeller Health (ResMed)
- Sensirion AG
- Teva Pharmaceutical Industries Ltd.
- Vectura Group Limited (Philip Morris International Inc.)
Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/smart-inhalers-market
COVID-19 Impact Overview:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Key Market Segmentation:
Breakup by Product:
Inhalers
- Dry Powdered Inhaler
- Metered Dose Inhaler
Nebulizers
Breakup by Indication:
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Stores
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
TOC for the Smart Inhalers Market Research Report:
- Preface
- Scope and Methodology
- Executive Summary
- Introduction
- Global Smart Inhalers Market
- SWOT Analysis
- Value Chain Analysis
- Price Analysis
- Competitive Landscape
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
